Deciphera Pharmaceuticals, Inc. Insider Trading for February 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Deciphera Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Deciphera Pharmaceuticals, Inc. for February 2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 25 2019 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | M | 3.95 | 24,500 | 96,775 | 15,050 | |
Feb 25 2019 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Buy | M | 3.95 | 24,500 | 96,775 | 24,500 | 0 to 24.5 K |
Feb 20 2019 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | M | 1.89 | 1,500 | 2,835 | 166,508 | |
Feb 20 2019 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Sell | S | 30.00 | 1,500 | 45,000 | 0 | 1.5 K to 0 (-100.00 %) |
Feb 20 2019 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Buy | M | 1.89 | 1,500 | 2,835 | 1,500 | 0 to 1.5 K |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 1.89 | 17,782 | 33,608 | 113,408 | |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 1.89 | 1,101 | 2,081 | 131,190 | |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Sell | S | 28.04 | 17,782 | 498,604 | 0 | 17.8 K to 0 (-100.00 %) |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Buy | M | 1.89 | 17,782 | 33,608 | 17,782 | 0 to 17.8 K |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Sell | S | 28.01 | 1,101 | 30,842 | 0 | 1.1 K to 0 (-100.00 %) |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Buy | M | 1.89 | 1,101 | 2,081 | 1,101 | 0 to 1.1 K |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Option Exercise | M | 1.89 | 3,997 | 7,554 | 539,635 | |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Option Exercise | M | 1.89 | 4,934 | 9,325 | 543,632 | |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Option Exercise | M | 1.89 | 500 | 945 | 548,566 | |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Sell | S | 30.00 | 3,997 | 119,913 | 0 | 4 K to 0 (-100.00 %) |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Buy | M | 1.89 | 3,997 | 7,554 | 3,997 | 0 to 4 K |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Sell | S | 28.01 | 4,934 | 138,193 | 0 | 4.9 K to 0 (-100.00 %) |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Buy | M | 1.89 | 4,934 | 9,325 | 4,934 | 0 to 4.9 K |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Sell | S | 28.00 | 500 | 14,000 | 0 | 500 to 0 (-100.00 %) |
Feb 19 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Buy | M | 1.89 | 500 | 945 | 500 | 0 to 500 |
Feb 07 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Option Exercise | M | 1.89 | 2,595 | 4,905 | 135,813 | |
Feb 07 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Sell | S | 28.02 | 2,595 | 72,704 | 0 | 2.6 K to 0 (-100.00 %) |
Feb 07 2019 | DCPH | Deciphera Pharmace ... | Bristol James Arthur | Director | Buy | M | 1.89 | 2,595 | 4,905 | 2,595 | 0 to 2.6 K |
Feb 01 2019 | DCPH | Deciphera Pharmace ... | Taylor Michael Douglas | President and CEO | Option Exercise | A | 26.35 | 263,000 | 6,930,050 | 263,000 | |
Feb 01 2019 | DCPH | Deciphera Pharmace ... | Ruddy Stephen B. | Chief Technical Off ... | Option Exercise | A | 26.35 | 52,000 | 1,370,200 | 52,000 | |
Feb 01 2019 | DCPH | Deciphera Pharmace ... | Morl Christopher John | Chief Business Offi ... | Option Exercise | A | 26.35 | 52,000 | 1,370,200 | 52,000 | |
Feb 01 2019 | DCPH | Deciphera Pharmace ... | Martin Daniel C. | Chief Commercial Of ... | Option Exercise | A | 26.35 | 52,000 | 1,370,200 | 52,000 | |
Feb 01 2019 | DCPH | Deciphera Pharmace ... | Kelly Thomas Patrick | Chief Financial Off ... | Option Exercise | A | 26.35 | 75,000 | 1,976,250 | 75,000 | |
Feb 01 2019 | DCPH | Deciphera Pharmace ... | Flynn Daniel Lee | Chief Scientific Of ... | Option Exercise | A | 26.35 | 75,000 | 1,976,250 | 75,000 |